While pioglitazone is an effective insulin sensitizer, its use needs to be carefully weighed against side effects that include risk of bone fractures, weight gain, edema, and increased incidence of heart failure, particularly when prescribed at high doses or when used in combination with SUOs or insulin [26–28]. Here, INS is linked to heart failure.